Location History:
- Munich, DE (2014)
- Essen, DE (2016 - 2017)
Company Filing History:
2 out of 133 
2 out of 1,975 
1 out of 132 
Years Active: 2014-2017
Title: Carsten Juergen Kirschning: Innovator in Immunology
Introduction
Carsten Juergen Kirschning is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of three patents to his name, Kirschning's work focuses on the development of novel therapeutic agents targeting Toll-like receptors.
Latest Patents
One of Kirschning's latest patents is titled "Agonists and antagonists of toll-like receptor (TLR) 13." This invention provides agonists and antagonists of TLR 13, including nucleic acids that can be used as pharmaceutical agents. The invention also outlines in vitro methods utilizing these nucleic acids. Another notable patent is "TLR2 antagonistic antibody and use thereof," which describes a cross-reactive antibody that inhibits immune cell activation mediated by TLR2. This patent includes details on an isolated nucleic acid or vector coding for the antibody's variable regions and a pharmaceutical composition for treating inflammatory processes and infections.
Career Highlights
Throughout his career, Kirschning has worked with esteemed organizations such as Technische Universität München and Amgen Inc. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Some of Kirschning's notable coworkers include Guangxun Meng and Hermann Wagner. Their collaborative efforts have further enriched the research landscape in immunology.
Conclusion
Carsten Juergen Kirschning's innovative work in immunology, particularly through his patents on Toll-like receptors, showcases his dedication to advancing medical science. His contributions have the potential to impact therapeutic approaches for various inflammatory conditions and infections.